The content on this page was provided by an independent third party and syndicated by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content.

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease

CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Spikevax®, the Company’s COVID-19 vaccine, in children 6 months through 11 years of age who are at increased risk for COVID-19 disease. The Company’s COVID-19 vaccine, mRNA-1273, was previously available for pediatric populations under Emergency Use Authorization (EUA).

“COVID-19 continues to pose a significant potential threat to children, especially those with underlying medical conditions. Vaccination can be an important tool for protecting our youngest against severe disease and hospitalization,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We appreciate the FDA’s diligent scientific review and approval of Spikevax for pediatric populations at increased risk for COVID-19 disease.”

Moderna expects to have its updated Spikevax vaccine available for eligible populations in the U.S. for the 2025-2026 respiratory virus season.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Spikevax® is a registered trademark of Moderna.

INDICATION

SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine to protect you against COVID-19. SPIKEVAX is for people who are:

  • 65 years of age and older, or

  • 6 months through 64 years of age at high risk for severe COVID-19.

Vaccination with SPIKEVAX may not protect all people who receive the vaccine.

IMPORTANT SAFETY INFORMATION

You or your child should not get SPIKEVAX if you had a severe allergic reaction after a previous dose of SPIKEVAX or any Moderna COVID-19 vaccine or to any ingredient in these vaccines.

What are the risks of SPIKEVAX?

There is a very small chance that SPIKEVAX could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to 1 hour after getting a dose of SPIKEVAX. For this reason, the healthcare provider may ask you or your child to stay for a short time at the place where you or your child received your vaccine. Signs of a severe allergic reaction can include:

  • Trouble breathing

  • Swelling of your face and throat

  • A fast heartbeat

  • A rash all over your body

  • Dizziness and weakness

  • Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received mRNA COVID-19 vaccines. Myocarditis and pericarditis following mRNA COVID-19 vaccines have occurred most commonly in males 12 years through 24 years of age. You should seek medical attention right away if you or your child has any of the following symptoms after receiving Spikevax, particularly during the 2 weeks after receiving a dose of the vaccine: chest pain, shortness of breath, feelings of having a fast-beating, fluttering, or pounding heart. Additional symptoms in children may include fainting, irritability, poor feeding, lack of energy, vomiting, pain in the abdomen, or cool, pale skin.

Other side effects that have been reported include:

  • Injection site reactions: pain, tenderness and swelling of the lymph nodes in the same arm of the injection or in the groin, swelling (hardness), and redness

  • General side effects: fatigue, headache, muscle pain, joint pain, chills, nausea and vomiting, fever, rash, irritability/crying, sleepiness, and loss of appetite.

  • Fainting and febrile seizures (convulsions during a fever) were also reported

Tell the healthcare provider about all of your or your child’s medical conditions, including if you or your child:

  • have any allergies

  • had a severe allergic reaction after receiving a previous dose of any COVID-19 vaccine

  • have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)

  • have a fever

  • have a bleeding disorder or are on a blood thinner

  • are immunocompromised or on a medicine that affects your immune system

  • are pregnant or plan to become pregnant

  • are breastfeeding

  • have received any other COVID-19 vaccine

  • have ever fainted in association with an injection

These may not be all the possible side effects of SPIKEVAX. Ask your healthcare provider about any side effects that concern you. You may report side effects to Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or http://vaers.hhs.gov.

Please see the SPIKEVAX Full Prescribing Information.

Moderna Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding the availability of an updated Spikevax vaccine for eligible populations in the U.S. for the 2025-2026 respiratory virus season. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

Moderna Contacts

Media:
Chris Ridley
Head of Global Media Relations
+1 617-800-3651
Chris.Ridley@modernatx.com

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
+1 617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media

Terra Innovatum to Participate in Upcoming H.C. Wainwright Virtual Conference on July 15, 2025

Terra Innovatum to Participate in Upcoming H.C. Wainwright Virtual Conference on July 15, 2025

NEW YORK, NY and AUSTIN, TX / ACCESS Newswire / July 10, 2025 / Terra Innovatum Srl (“Terra Innovatum,” or the “Company”), a developer of…

July 10, 2025

Gladstone Land Announces Monthly Cash Distributions for July, August and September 2025 and Earnings Release and Conference Call Dates for the Second Quarter Ended June 30, 2025

Gladstone Land Announces Monthly Cash Distributions for July, August and September 2025 and Earnings Release and Conference Call Dates for the Second Quarter Ended June 30, 2025

MCLEAN, VA / ACCESS Newswire / July 10, 2025 / Gladstone Land Corporation (Nasdaq:LAND) (“Gladstone Land” or the “Company”) announced today that its board of…

July 10, 2025

Gladstone Commercial Corporation Announces Monthly Cash Distributions for July, August and September 2025 and Earnings Release and Conference Call Dates for its Second Quarter Ended June 30, 2025

Gladstone Commercial Corporation Announces Monthly Cash Distributions for July, August and September 2025 and Earnings Release and Conference Call Dates for its Second Quarter Ended June 30, 2025

MCLEAN, VA / ACCESS Newswire / July 10, 2025 / Gladstone Commercial Corporation (Nasdaq:GOOD) (the “Company”) announced today that its board of directors declared cash…

July 10, 2025

Gladstone Investment Announces Monthly Cash Distributions for July, August and September 2025, and Earnings Release and Conference Call Dates for the First Fiscal Quarter

Gladstone Investment Announces Monthly Cash Distributions for July, August and September 2025, and Earnings Release and Conference Call Dates for the First Fiscal Quarter

MCLEAN, VA / ACCESS Newswire / July 10, 2025 / Gladstone Investment Corporation (Nasdaq:GAIN) (the “Company”) announced today that its board of directors declared the…

July 10, 2025

Gladstone Capital Announces Monthly Cash Distributions for July, August and September 2025 and Conference Call Date

Gladstone Capital Announces Monthly Cash Distributions for July, August and September 2025 and Conference Call Date

MCLEAN, VA / ACCESS Newswire / July 10, 2025 / Gladstone Capital Corporation (Nasdaq:GLAD) (the “Company”) announced today that its board of directors declared the…

July 10, 2025

Legacy in Motion: Preparing the Next Generation at Bradley Wealth

Legacy in Motion: Preparing the Next Generation at Bradley Wealth

SCOTTSDALE, AZ / ACCESS Newswire / July 10, 2025 / Michael Bradley has spent more than 30 years building one of the most trusted independent…

July 10, 2025

CoreStack Achieves Microsoft Solutions Partner Designation With Azure Certified Software for Its NextGen Cloud Governance and Security Platform

CoreStack Achieves Microsoft Solutions Partner Designation With Azure Certified Software for Its NextGen Cloud Governance and Security Platform

BELLEVUE, WA / ACCESS Newswire / July 10, 2025 / CoreStack, a leading provider of NextGen Cloud Optimization, and Governance and Security, today announced it…

July 10, 2025

Agent Boost Marketing Joins Forces with AmeriLife’s Senior Market Advisors

Agent Boost Marketing Joins Forces with AmeriLife’s Senior Market Advisors

Partnership creates geographic advantages aligned with SMA’s strategic growth plan while diversifying the distribution of individual insurance products NASHVILLE, TENN. AND CLEARWATER, FLA. / ACCESS…

July 10, 2025

Voices Announces Upcoming Launch, Unveiling Voice Data Solution to Power Responsible Voice AI

Voices Announces Upcoming Launch, Unveiling Voice Data Solution to Power Responsible Voice AI

NEW YORK, NY / ACCESS Newswire / July 10, 2025 / Voices, the world’s most comprehensive voice solutions provider, today announced it will officially be…

July 10, 2025

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs

Company strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally approved for CID, to regulatory approval and commercialization…

July 10, 2025

Abacus Raises $6.6M Seed Round to Build Agentic CPA Assistants for the Modern Accounting Firm

Abacus Raises $6.6M Seed Round to Build Agentic CPA Assistants for the Modern Accounting Firm

Menlo Ventures leads round backing intelligent assistants that help tax firms scale amid rising workloads and shrinking headcount. SAN FRANCISCO, CA / ACCESS Newswire /…

July 10, 2025

Brenmiller Energy Releases Annual ESG Report Highlighting Commercial Expansion, Carbon Tracking, and Sustainable Innovation

Brenmiller Energy Releases Annual ESG Report Highlighting Commercial Expansion, Carbon Tracking, and Sustainable Innovation

Report details progress in Environmental, Social, and Governance priorities and strengthens investor transparency The full ESG report is available: HERE To view Brenmiller’s latest investor…

July 10, 2025

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19…

July 10, 2025

Arrive AI selects Synoptek as a Strategic IT Partner to Power Global Expansion

Arrive AI selects Synoptek as a Strategic IT Partner to Power Global Expansion

INDIANAPOLIS, IN AND COSTA MESA, CA / ACCESS Newswire / July 10, 2025 / Arrive AI (NASDAQ:ARAI) – a pioneering autonomous delivery network anchored by…

July 10, 2025

Electrovaya Achieves UL2580 Certification for Over 400 Next-Generation Lithium-Ion Battery Models

Electrovaya Achieves UL2580 Certification for Over 400 Next-Generation Lithium-Ion Battery Models

Latest battery systems feature enhanced performance and include 54Ah ceramic cell to be mass produced in Jamestown, NY Passed the most stringent safety testing in…

July 10, 2025

Unusual Machines Expands Leadership Team with Appointment of Tim Manton as Corporate Controller

Unusual Machines Expands Leadership Team with Appointment of Tim Manton as Corporate Controller

New hire supports operational scale-up and financial infrastructure as company ramps U.S. motor manufacturing ORLANDO, FLORIDA / ACCESS Newswire / July 9, 2025 / Unusual…

July 9, 2025

LAWSUIT: Pennsylvania Jury Awards $5.6M to Parents of Brain Damaged Child After Botched Birth and Invasion of Privacy

LAWSUIT: Pennsylvania Jury Awards $5.6M to Parents of Brain Damaged Child After Botched Birth and Invasion of Privacy

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / July 9, 2025 / A Pennsylvania jury has awarded $5.6 million to the family of a child left debilitated…

July 9, 2025

Step Into the Smurfs’ World With Goose Creek’s New Candle Collection

Step Into the Smurfs’ World With Goose Creek’s New Candle Collection

Eight enchanting fragrances inspired by the iconic characters and cozy forest village. LIBERTY, KENTUCKY / ACCESS Newswire / July 9, 2025 / Goose Creek is…

July 9, 2025

Interactive Strength Inc. (Nasdaq: TRNR) Receives “Buy” Rating and $15 Price Target in Maxim Group Research Initiation

Interactive Strength Inc. (Nasdaq: TRNR) Receives “Buy” Rating and $15 Price Target in Maxim Group Research Initiation

First comprehensive sell-side report on TRNR cites more than 800% growth in expected 2025 revenue Valuation driven by stock-for-stock M&A model and potential crypto-treasury upside…

July 9, 2025

Certidox Adds AI-Powered QR Code Analysis to Free App for Document and Link Authentication

Certidox Adds AI-Powered QR Code Analysis to Free App for Document and Link Authentication

Certidox releases a major update to its free mobile app, adding AI-powered QR code analysis to detect phishing and fraud. The platform lets users instantly…

July 9, 2025

Preston Spire Taps Dustin Black to Supercharge “Good Wins” Creative Philosophy

Preston Spire Taps Dustin Black to Supercharge “Good Wins” Creative Philosophy

25-Year Industry Veteran to Guide Agency Through AI Evolution with “Culture of Curiosity” and Collaborative Leadership MINNEAPOLIS, MN / ACCESS Newswire / July 9, 2025…

July 9, 2025

Tidal Wave Auto Spa Continues Growth in Florida With Spring Hill Location Opening

Tidal Wave Auto Spa Continues Growth in Florida With Spring Hill Location Opening

Top Four Conveyor Car Wash Company Celebrates Grand Opening with Free Washes THOMASTON, GEORGIA / ACCESS Newswire / July 9, 2025 / Tidal Wave Auto…

July 9, 2025

Locally Owned, Physician-Led: A New Standard in Mobile Wound Care for South Carolina

Locally Owned, Physician-Led: A New Standard in Mobile Wound Care for South Carolina

Skip the Clinic – New Mobile Wound Care Service Offers Cutting-Edge Treatment at Home GREENVILLE, SOUTH CAROLINA / ACCESS Newswire / July 9, 2025 /…

July 9, 2025

Rivers are Life Highlights River Conservation at Wildlands 2025

Rivers are Life Highlights River Conservation at Wildlands 2025

Organization hosts river cleanup to support river conservation and awareness BIG SKY, MT / ACCESS Newswire / July 9, 2025 / Rivers are Life, a…

July 9, 2025

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement

Early positive consumer testimonials from initial Company product sampling Sublingual nano technology delivers caffeine rapidly to the bloodstream, bringing its unique benefits to the pre-workout…

July 9, 2025

Augmentus Raises $11M to Scale Physical AI for High-Mix, Complex Robotic Surface Finishing and Welding

Augmentus Raises $11M to Scale Physical AI for High-Mix, Complex Robotic Surface Finishing and Welding

SINGAPORE, SG / ACCESS Newswire / July 9, 2025 / Augmentus, the developer of an intelligent no-code robotics solution, announced today that it has raised…

July 9, 2025

Ahead of World IVF Day, HRC Fertility Launches Innovative Clinical Trial with Gameto for More Approachable IVF

Ahead of World IVF Day, HRC Fertility Launches Innovative Clinical Trial with Gameto for More Approachable IVF

LOS ANGELES, CA / ACCESS Newswire / July 9, 2025 / HRC Fertility is proud to announce its participation in a groundbreaking clinical trial evaluating…

July 9, 2025

Crypto Tax Enforcement Is Back – Clear Start Tax Urges Traders to Avoid Costly Mistakes and Stay Compliant

Crypto Tax Enforcement Is Back – Clear Start Tax Urges Traders to Avoid Costly Mistakes and Stay Compliant

IRS letters targeting digital asset holders are on the rise – Clear Start Tax outlines what crypto traders need to know to protect themselves. IRVINE,…

July 9, 2025

AGFA HealthCare Achieves HITRUST I1 Certification, Demonstrating Its Commitment to and Compliance With Data Protection Standards, and Protecting Against Cybersecurity Threats

AGFA HealthCare Achieves HITRUST I1 Certification, Demonstrating Its Commitment to and Compliance With Data Protection Standards, and Protecting Against Cybersecurity Threats

HITRUST certification validates that AGFA HealthCare is operating using leading security practices to protect sensitive information. MORTSEL, BE / ACCESS Newswire / July 9, 2025…

July 9, 2025

North Shore Uranium Engages Investing News Network

North Shore Uranium Engages Investing News Network

VANCOUVER, BC / ACCESS Newswire / July 8, 2025 / North Shore Uranium Ltd. (TSX-V:NSU) (“North Shore” or the “Company“) is pleased to announce that…

July 8, 2025

Legal Dispute Arises Over Satisfied Mortgage in Queens Foreclosure Case

Legal Dispute Arises Over Satisfied Mortgage in Queens Foreclosure Case

A New York foreclosure case involving a previously satisfied mortgage led to a key Appellate Division ruling. The court upheld the rights of a third-party…

July 8, 2025

New to The Street Announces Media Coverage of BitMine Immersion Technologies Inc., Including NewsOut Video PR Integration

New to The Street Announces Media Coverage of BitMine Immersion Technologies Inc., Including NewsOut Video PR Integration

NEW YORK CITY, NEW YORK / ACCESS Newswire / July 8, 2025 / New to The Street, the award-winning national TV business show airing weekly…

July 8, 2025

Curative Health Insurance Company’s Financial Strength Rating Affirmed by AM Best for Third Consecutive Year

Curative Health Insurance Company’s Financial Strength Rating Affirmed by AM Best for Third Consecutive Year

AUSTIN, TX / ACCESS Newswire / July 8, 2025 / Curative Insurance Company is proud to announce that AM Best, the global credit rating agency…

July 8, 2025

CMG Welcomes David Schwartz, Area Sales Manager

CMG Welcomes David Schwartz, Area Sales Manager

NEW YORK CITY, NEW YORK / ACCESS Newswire / July 8, 2025 / CMG Home Loans, the retail division of well-capitalized privately held mortgage lender,…

July 8, 2025

PrivateJet.com Launches a New Era in On-Demand Luxury Air Travel

PrivateJet.com Launches a New Era in On-Demand Luxury Air Travel

MIAMI, FL / ACCESS Newswire / July 8, 2025 / PrivateJet.com (PrivateJet.com LLC), the leading domain in private aviation, has officially launched. The platform guides…

July 8, 2025

Skip Barber Racing School to Build First-Ever Racing Resort in Ixtapan de la Sal, Mexico

Skip Barber Racing School to Build First-Ever Racing Resort in Ixtapan de la Sal, Mexico

NEW YORK, NY AND IXTAPAN DE LA SAL, MEXICO / ACCESS Newswire / July 8, 2025 / Skip Barber Racing School (SBRS), widely regarded as…

July 8, 2025

CoTec Investment Mkango and Hypromag Announces First Production from Commercial-Scale Recycled Rare Earth Alloy Production in the UK

CoTec Investment Mkango and Hypromag Announces First Production from Commercial-Scale Recycled Rare Earth Alloy Production in the UK

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / July 8, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec” or the “Company”) is pleased to note that Mkango…

July 8, 2025

New, FREE Mid-Year Real Estate Market Report From The CE Shop Offers Actionable Insights From Industry Leaders

New, FREE Mid-Year Real Estate Market Report From The CE Shop Offers Actionable Insights From Industry Leaders

The CE Shop provides the tips needed for real estate business owners, brokerages, and leaders to thrive throughout the rest of 2025 and beyond DENVER,…

July 8, 2025

Coca Access and Benefit Sharing Agreement Authorized by Peru’s National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indications of Coca

Coca Access and Benefit Sharing Agreement Authorized by Peru’s National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indications of Coca

Magdalena is focused on developing novel, natural prescription medicines derived from plants for mental health indications SAN FRANCISCO, CA / ACCESS Newswire / July 8,…

July 8, 2025

Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of  First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Investigator initiated exploratory clinical study being conducted in Israel pursuant to agreement with collaboration partner, PeriNess Company evaluating systemic recombinant human DNase I (DNase I)…

July 8, 2025